Lin Zong

Lin Zong


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 December 2025 in Molecular Neurobiology
Verified
Journal Article
Open access
ZZZhonghua Zhang
Zhonghua Zhang
JZJingbei Zhang
Jingbei Zhang
LZLidong Zhang
Lidong Zhang
LZLin Zong
Lin Zong
Subarachnoid hemorrhage (SAH) is a destructive subtype of stroke characterized by a high mortality and morbidity rate (45-50%) and a poor neurologic prognosis, encompassing both neurological and psychiatric impairments. It will be more imperative to explore new therapeutic strategies for early brain injury (EBI) to enhance the prognosis of patients with SAH. First, we investigated the role of endoplasmic reticulum stress (ERS) and mitochondrial stress (MS) in mediating the IP3R1-GRP75-VDAC1 Ca2⁺ channeling complex within the first 72 h following SAH in mice. Neurological function was assessed prior to euthanasia, and brain water content was measured post-sacrifice in each group. The ultrastructural composition of mitochondria-associated membrane (MAM) was examined using transmission electron microscopy (TEM). Protein expressions related to ERS, MS, and apoptosis were evaluated by immunofluorescence and Western blot. Metformin (Met) administration improved neurological scores and reduced brain edema at 24 h post-SAH, likely through ameliorating ERS- and MS-mediated Ca2⁺ dysregulation. Finally, the beneficial effect of Met was further confirmed in an in vitro SAH model, yielding consistent results. Stimulation of arterial blood aggravates the ERS and MS through the PTP1B/AKT axis, further affecting the structure and function of the MAM following SAH. The MAM formation mediates the IP3R1-GRP75-VDAC1 complex, playing an important role in Ca2+ transport. The Met treatment could ameliorate ER stress, MS, and Ca2+ overload, further alleviating the EBI of SAH.

18 June 2026 in Frontiers in Surgery
Verified
Journal Article
Open access
LLLiping Li
Liping Li
ZZZhonghua Zhang
Zhonghua Zhang
LZLin Zong
Lin Zong
Artificial intelligence (AI) is transforming neurovascular surgery by improving diagnostic accuracy, risk prediction, treatment planning, and patient outcomes. This narrative review examines AI across the continuum of cerebrovascular care, from initial diagnosis through intervention and long-term prognostication. We discuss how machine learning, deep learning, computer vision, and natural language processing are applied to diverse data sources including neuroimaging, electronic health records, and intraoperative inputs. AI algorithms augment clinical expertise in diagnosis by delivering high speed and precision for tasks such as detecting large vessel occlusions, characterizing aneurysm morphology, and differentiating hemorrhage subtypes. Beyond detection, AI models are increasingly used for risk stratification—predicting aneurysm rupture, functional recovery after stroke, and post-intervention complications. AI also shows promise in therapeutic decision-making through pre-operative simulation, robotic-assisted microsurgery, and intraoperative guidance systems, with preliminary evidence suggesting potential improvements in procedural safety and efficacy (though most intraoperative AI studies remain at the proof-of-concept or single-center retrospective stage). Despite these developments, challenges remain, including algorithmic bias, limited generalizability, lack of interpretability, data privacy concerns, and regulatory barriers. Successful deployment requires seamless workflow integration and a clear understanding that AI assists, not replaces, the neurosurgeon. The convergence of AI with precision medicine holds promise for personalized, data-driven care through synergistic human-AI collaboration.

8 July 2026 in Cellular Signalling
Verified
Journal Article
Open access
ZZZhonghua Zhang
Zhonghua Zhang
PSPeipei Shen
Peipei Shen
LZLin Zong
Lin Zong
LZLidong Zhang
Lidong Zhang
Aneurysmal subarachnoid hemorrhage (SAH) is a devastating acute hemorrhagic stroke. The communication between the endoplasmic reticulum (ER) and mitochondria, mediated by mitochondria-associated membranes (MAMs), is critical for neuronal homeostasis. This study investigates whether disrupted ER-mitochondrial coupling at MAMs, characterized by altered contact distance and area, contributes to early brain injury (EBI) after SAH by facilitating pathological Ca2+ transfer via the IP3R1/GRP75/VDAC1 complex. We further explore the therapeutic potential of targeting this complex. Primary cortical neurons exposed to oxyhemoglobin (OxyHb) and a mouse model of SAH were employed. The dynamic changes in MAM structure (ER-mitochondria distance, contact length), ER stress, and Ca2+ handling were assessed. Using shRNA-mediated knockdown and lentiviral overexpression of IP3R1, we evaluated its role in modulating MAM integrity, ER stress markers (p-eIF2α, ATF4, CHOP), Ca2+ dynamics, and neuronal apoptosis. SAH induction led to a significant decrease in ER-mitochondria distance and an increase in MAM contact area, concurrent with upregulation of the IP3R1/GRP75/VDAC1 complex. These changes were associated with elevated ER stress and increased cytosolic and mitochondrial Ca2+ levels. Knockdown of IP3R1 rescued the SAH-induced ultrastructural changes at MAMs, attenuated ER stress, and reduced Ca2+ overload, thereby decreasing neuronal apoptosis and alleviating neurological deficits. Conversely, IP3R1 overexpression exacerbated these pathological outcomes. Pathological enhancement of ER-mitochondria coupling via the IP3R1/GRP75/VDAC1 complex is a key driver of Ca2+-mediated neuronal apoptosis in EBI after SAH. Targeted downregulation of IP3R1 represents a promising therapeutic strategy to restore MAM homeostasis and mitigate brain injury.

13 November 2026 in Frontiers in Surgery
Verified
Journal Article
Open access
PDF file
JZJieping Zhou
Jieping Zhou
LCLiying Cui
Liying Cui
ZZZhonghua Zhang
Zhonghua Zhang
LZLin Zong
Lin Zong
Background: Spinal anesthesia in patients aged ≥80 years is often challenging due to severe degenerative changes of the lumbar spine. The conventional paramedian approach may still encounter difficulties. This study aimed to compare the efficacy and safety of a lateral (modified paramedian) approach with the conventional paramedian approach for spinal anesthesia in patients aged ≥80 years undergoing hip surgery. Methods: This retrospective cohort study was conducted at Jinling Hospital between January 2022 and December 2025. In this retrospective cohort study, 144 patients aged ≥80 years who underwent hip surgery under spinal anesthesia were included. 65 patients (MP group) received the lateral approach, and 79 patients (CP group) received the conventional paramedian approach. A 1:1 propensity score matching (PSM) was performed to balance age, sex, BMI, ASA physical status, and spinal degeneration grade. The primary outcome was the first-attempt success rate. Secondary outcomes included anesthesia-to-surgery time, needle repositioning required, repositioning rate, incidence of complications, and postoperative hospital stay. Results: After PSM, 65 patients remained in each group. Baseline characteristics were well-balanced (all P > 0.05). The first-attempt success rate was higher in the lateral group than in the conventional paramedian group (56.9% vs. 50.8%), but the difference was not statistically significant (OR 1.27, 95% CI 0.62–2.61, P = 0.617). The lateral approach significantly reduced anesthesia-to-surgery time (mean difference –6.40 min, 95% CI –11.32 to –1.48, P = 0.012) and the incidence of postoperative back pain (12.3% vs. 27.7%, OR 0.37, 95% CI 0.15–0.89, P = 0.032). Conclusions: The lateral (modified paramedian) approach was associated with significantly shorter anesthesia-to-surgery time and a lower incidence of postoperative back pain. Although the first-attempt success rate was numerically higher with the lateral approach, the difference did not reach statistical significance, and the current data do not establish its superiority. The lateral approach may serve as a valuable alternative for this vulnerable population, though further prospective evaluation is warranted. As a retrospective single-center study, residual confounding and selection bias cannot be fully excluded.

29 July 2026 in Frontiers in Medicine
Verified
Journal Article
Open access
PDF file
BZBaohua Zhang
Baohua Zhang
YHYang Han
Yang Han
LZLin Zong
Lin Zong
LZLidong Zhang
Lidong Zhang
Background: Dexmedetomidine is a commonly used perioperative sedative and is generally associated with a lower risk of postoperative delirium; however, a few cases suggest that it may also cause delirium-like neuropsychiatric reactions in certain patients. Although reserpine is used less frequently, the changes in central neurotransmitters after long-term exposure and recent discontinuation remain a concern. At present, there are no reports of acute behavioral abnormalities in patients who received dexmedetomidine sedation perioperatively after recent discontinuation of long-term reserpine treatment. Case presentation: A 63-year-old hypertensive woman, who had been taking reserpine for 10 years and discontinued it 7 days prior to surgery, underwent arthroscopic meniscectomy under subarachnoid anesthesia. After satisfactory anesthesia, she was given intravenous dexmedetomidine for stress sedation. During the infusion, the patient suddenly experienced disorientation, incoherent speech, significant resistance, and agitation, accompanied by a further increase in blood pressure. Immediately after an intravenous bolus of remimazolam 2 mg, the symptoms rapidly subsided, the patient returned to a sedated state, and the surgery was successfully completed. Postoperatively, the patient was conscious, did not exhibit similar abnormal behavior, had no recollection of the episode, and was discharged smoothly on the 3rd postoperative day. Conclusion: This case suggests that rare acute hyperactive delirium-like episodes may occur in patients who have recently discontinued long-term reserpine therapy and are receiving dexmedetomidine sedation during the perioperative period. Clinically, careful titration and close monitoring of mental status and hemodynamics are necessary.